507759 LIMECHM

Lime Chemicals Share Price

₹19.25 +0.89 (4.85%)

04 Mar, 2025 06:03

SIP TrendupStart SIP in LIMECHM

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -10.26%
  • Over 3 Month -26.44%
  • Over 6 Month -27.82%
  • Over 1 Year -47.4%
SIP Lightning

Smart Investing Starts Here Start SIP with Lime Chemicals for Steady Growth!

Invest Now

Lime Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Lime Chemicals Financials

Lime Chemicals Technicals

EMA & SMA

Current Price
₹19.25
+ 0.89 (4.85%)
pointer
  • stock-down_img
  • Bearish Moving Average 14
  • stock-up_img
  • Bullish Moving Average 2
  • 20 Day
  • ₹20.13
  • 50 Day
  • ₹21.82
  • 100 Day
  • ₹23.76
  • 200 Day
  • ₹25.40

Resistance and Support

18.49 Pivot Speed
  • R3 21.84
  • R2 20.92
  • R1 19.41
  • S1 16.98
  • S2 16.06
  • S3 14.55

What's your outlook on Lime Chemicals?

You can only vote for once

Lime Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-13 Quarterly Results

Lime Chemicals F&O

Lime Chemicals Shareholding Pattern

No data available.

About Lime Chemicals

  • NSE Symbol
  • LIMECHM
  • BSE Symbol
  • 507759
  • ISIN
  • INE891G01011

Similar Stocks to Lime Chemicals

Lime Chemicals FAQs

Lime Chemicals share price is ₹19 As on 04 March, 2025 | 05:49

The Market Cap of Lime Chemicals is ₹12.5 Cr As on 04 March, 2025 | 05:49

The P/E ratio of Lime Chemicals is 231 As on 04 March, 2025 | 05:49

The PB ratio of Lime Chemicals is 7.2 As on 04 March, 2025 | 05:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23